Top Story
DEA Schedule III Cannabis Rescheduling August 2026 Morning Update Federal Administrative Review Nears Final Phase as Industry Prepares for Transformative Tax and Banking Implications
TL;DR: The DEA’s formal rulemaking process for cannabis rescheduling from Schedule I to Schedule III reached a critical phase in August 2026, with the administrative
Top Movers
Latest Analysis
DEA Schedule III Cannabis Rescheduling August 2026 Morning Update Federal Administrative Review Nears Final Phase as Industry Prepares for Transformative Tax and Banking Implications
TL;DR: The DEA’s formal rulemaking process for cannabis rescheduling from Schedule I to Schedule III reached a critical phase in August 2026, with the administrative
Cresco Labs CRLBF Wednesday August 19 2026 Morning Analysis Illinois Multi-State Retail Portfolio and Branded CPG Scale Position Premium MSO for Q3 Earnings Leverage
TL;DR: Cresco Labs (OTC: CRLBF) enters the second half of 2026 with a vertically integrated multi-state platform anchored by dominant Illinois market share and a
Green Thumb Industries GTBIF Tuesday August 18 2026 Midday Analysis Illinois Anchor Revenue and High-Margin CPG Portfolio Sustain Free Cash Flow Leadership as Q3 Cannabis Earnings Season Approaches
TL;DR: Green Thumb Industries (GTBIF) enters the Q3 2026 earnings window with one of the strongest free cash flow profiles among large-cap U.S. multi-state operators,
Cannabis Q3 2026 Earnings Season Preview MSO Reporting Calendar and Key Performance Benchmarks Define Critical Catalyst Window for Cannabis Equities
TL;DR: The Q3 2026 cannabis earnings season represents one of the most consequential reporting cycles in recent memory, with investors focused on free cash flow
Organigram Holdings OGI Sunday August 16 2026 Evening Analysis Canadian LP Cost Structure Optimization and International Medical Expansion Position Profitability Recovery Ahead of Q3 Cannabis Earnings Season
TL;DR: Organigram Holdings (NASDAQ: OGI) enters the Q3 cannabis earnings season with a structurally improved cost base following 18 months of facility rationalization and a
Trulieve Cannabis TCNNF Sunday August 16 2026 Midday Analysis Florida Market Dominance and Southeast Retail Density Drive Sustained Free Cash Flow Leadership Among Large-Cap US MSOs
TL;DR: Trulieve Cannabis remains the dominant cannabis operator in Florida with over 180 dispensaries, generating more free cash flow than any other US multi-state operator.